Skip to main content
OpenTrials
Completed

NCT Number: NCT01791803

Smoking Cessation After Hospitalization for a Cardiopulmonary Illness

Smoking-related cardiopulmonary diseases account for a large number of hospital admissions. We investigated the efficacy of hypnotherapy as an aid to a counseling-based smoking cessation program in improving quit rates of hospitalized smoking patients at 12 and 26 weeks after hospital discharge. We compared outcomes with hospitalized patients who received more conventional therapy, namely nicotine replacement therapy, or patients who decided to quit on their own. We also compared smoking cessation rates at 12 and 26 weeks after hospitalization among patients admitted with a cardiac or a pulmonary diagnosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Cessation Behavior Health Behavior

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

North Shore Medical Center

Salem, Massachusetts, 01970, United States

About this study

Hospitalized patients with a cardiopulmonary diagnosis who were contemplating quitting were recruited into 4 groups: Hypnotherapy, Nicotine replacement therapy (NRT), both hypnotherapy and NRT, and self-quit group. All patients received self-help brochures and in-hospital counseling. Intervention groups received more extensive counseling, free NRT supply for a month and/or a 90 minute hypnotherapy session within 2 weeks of discharge. They also had follow up telephone counseling at 1,2,4,8 and 12 weeks after discharge. 7 day prevalence of tobacco abstinence rates at 26 weeks after hospitalization were verified by self report and urinary Cotinine levels.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hospitalized patients with a Cardiopulmonary admission.

Exclusion criteria

  • Terminal illness, history of Serious Psychiatric illness or substance abuse, Pregnancy, Cognitive or language barriers.

Treatment and study plan

Hypnotherapy

Behavioral

One 90 minute session within 2 weeks of hospital discharge

Other names: hypnosis

nicotine

Drug

free one month supply after hospital discharge

Other names: Nicotine replacement therapy

Primary outcomes

  1. Abstinence From Smoking

    Time frame: at 26 weeks after hospitalization

    Assessed by 7-day prevalence of verified tobacco abstinence at 26 weeks after hospitalization for a cardiopulmoanry illness. Verification was confirmed biochemically by urine Cotinine testing or by telephone and discussion with a household proxy. Patients lost to follow up were considered to be persistent smokers.

Secondary outcomes

  1. Smoking Cessation

    Time frame: at 12 weeks after hospitalization

    Abstinence from smoking at 12 weeks after hospitalization was measured by self reported 7-day prevalence and verified urinary Cotinine test. This included participants in groups receiving hypnotherapy, NRT or both. Self quit group was not approached until 26 weeks after discharge. Patients lost to follow up were considered smokers.

  2. Smoking Abstinence Rate at 12 and 26 Weeks

    Time frame: 12 weeks and 26 weeks after hospital discharge

    Abstinence rates were calculated for patients hospitalized with a cardiac or a pulmonary diagnosis.

Sponsors and collaborators

Lead sponsor

North Shore Medical Center

Other

Registry information

Official study title

Smoking Cessation Treatment of CardioPulmonary Hospitalized Patients

Acronym: STOPP

Important dates

Study start
2006
Primary completion
2009
Study completion
2009
First posted
Feb 15, 2013
Registry last updated
May 19, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.